Bohn, Jan-Paul http://orcid.org/0000-0002-2066-7377
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 11 March 2022
Accepted: 25 March 2022
First Online: 14 April 2022
Conflict of interest
: J.-P. Bohn reports personal fees from AbbVie, Astra-Zeneca and Janssen for advisory board participation.